⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16297967 | 1.00 | — | — | |
| SCHEMBL7857262 | 1.00 | — | — | |
| SCHEMBL12608040 | 1.00 | — | — | |
| SCHEMBL7860508 | 0.94 | — | — | |
| SCHEMBL12606655 | 0.93 | — | — | |
| SCHEMBL12607439 | 0.92 | ADAM17 (0.31) | — | |
| SCHEMBL12856023 | 0.92 | — | — | |
| SCHEMBL13685729 | 0.92 | — | — | |
| SCHEMBL12608392 | 0.91 | — | — | |
| SCHEMBL16298212 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070021351-A1 | Liver/plasma concentration ratio for dosing hepatitis C virus protease inhibitor | SCHERING CORPORATION | 2007-01-25 | — | — | US | disclosed |
| US-20070021351-A1 | Liver/plasma concentration ratio for dosing hepatitis C virus protease inhibitor | SCHERING CORPORATION | 2007-01-25 | — | — | US | disclosed |